18th Dec 2020 14:21
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | AON plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.01 ordinary shares |
Date of dealing | 17 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities | 6,293,728 2.75 | 2,813,140 1.24 | ||||
(2) Derivatives (other than options) | 2,588,858 1.14 | 38,349 0.02 | ||||
(3) Options and agreements to purchase/sell |
| 26,300 0.01 | ||||
Total | 8,882,586 3.89 | 2,877,789 1.27 | ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) | |
Purchases(New Borrow)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 5,400
53 27 10 2 1 6,457 178 1 1 8 1 1 7 1 2 6 24 339 39 1 8 2 1,900 7 24 27 2 2 12 7 3 1 42 33 40 24 1,445 44 1 6 116 48 1 591 1 12 1 41 1 1 46 41 2 5 5 4 1
53 53 10 10 300 166 6,102 178 102 23 12 100 19 19 313 187 39 39 17 16 700 1,900 2 14 19 4 24 8 5 49 1,445 200 1 1 8 22 100 | N/A
210.1394 USD 210.1400 USD 210.7860 USD 210.8250 USD 211.2000 USD 211.3000 USD 211.3050 USD 211.3100 USD 211.3900 USD 211.4013 USD 211.4300 USD 211.4600 USD 211.4714 USD 211.5100 USD 211.5400 USD 211.5417 USD 211.6088 USD 211.6141 USD 211.6200 USD 211.6500 USD 211.6863 USD 211.6900 USD 211.6907 USD 211.7043 USD 211.7192 USD 211.7585 USD 211.7600 USD 211.7800 USD 211.7808 USD 211.8129 USD 211.8167 USD 211.8350 USD 211.8490 USD 211.8524 USD 211.8688 USD 211.8716 USD 211.8924 USD 211.9000 USD 211.9100 USD 211.9200 USD 211.9272 USD 211.9867 USD 211.9900 USD 211.9979 USD 212.0000 USD 212.0406 USD 212.0700 USD 212.0798 USD 212.0800 USD 212.1000 USD 212.1028 USD 212.1085 USD 212.3100 USD 212.7220 USD 212.7480 USD 212.8075 USD 213.2900 USD
210.1394 USD 210.1400 USD 210.7860 USD 210.8050 USD 211.2233 USD 211.2943 USD 211.3000 USD 211.3050 USD 211.3200 USD 211.3500 USD 211.4600 USD 211.4814 USD 211.5758 USD 211.5847 USD 211.5887 USD 211.5909 USD 211.6200 USD 211.6300 USD 211.6535 USD 211.6581 USD 211.6900 USD 211.6907 USD 211.7800 USD 211.8279 USD 211.8511 USD 211.8525 USD 211.8716 USD 211.8875 USD 211.8900 USD 211.8922 USD 211.8924 USD 211.9700 USD 212.0100 USD 212.0200 USD 212.2888 USD 212.7768 USD 213.3500 USD | |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
Equity Swap | Long Long Long Long Long Long
Short Short Short Short | 53 10 95 83 800 1,100
847 57 451 90 | 210.1395 USD 210.8050 USD 211.2996 USD 211.3113 USD 211.6577 USD 211.7148 USD
211.8852 USD 211.8861 USD 211.8862 USD 211.9386 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price (USD) | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure | 18 December 2020 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, e.g. call option | Written, or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) | Type, e.g. American, European etc. | Expiry date |
Call Option |
Written |
26,300 |
230.00 USD |
American |
15-Jan-21 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
Related Shares:
Aon Cl A Ord